St John's wort, hypericin, and imipramine: A comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term and long-term administration in normal and stressed rats

Molecular Psychiatry

Volumn 6, Issue 5, 2001, Pages 547-564

  Butterweck, V ^a,b   Winterhoff, H ^a   Herkenham, M ^b  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Antidepressant; Corticotropin releasing hormone; Gene expression regulation; Hypericum; Hypothalamic pituitary adrenal; Imipramine; In situ hybridization; Locus coeruleus; Norepinephrine; Paraventricular hypothalamic nucleus

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOTROPIN RELEASING FACTOR; HYPERICIN; IMIPRAMINE; NORADRENALIN; PROOPIOMELANOCORTIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FORCED SWIMMING TEST; GENE EXPRESSION REGULATION; HORMONAL REGULATION; HYPERICUM PERFORATUM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMOBILIZATION STRESS; IN SITU HYBRIDIZATION; LIGAND BINDING; LOCUS CERULEUS; MESSENGER RNA SYNTHESIS; NEUROTRANSMITTER RELEASE; NONHUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; RAT; THALAMUS MIDLINE NUCLEUS;

ADRENAL GLANDS; ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANTIDEPRESSIVE AGENTS; ARGININE VASOPRESSIN; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DRUG ADMINISTRATION SCHEDULE; GLUTAMATE DECARBOXYLASE; HIPPOCAMPUS; HYPERICUM; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMIPRAMINE; IN SITU HYBRIDIZATION; ISOENZYMES; LOCUS COERULEUS; MALE; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PERYLENE; PITUITARY GLAND; PLANTS, MEDICINAL; PRO-OPIOMELANOCORTIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT1; REFERENCE VALUES; RESTRAINT, PHYSICAL; RNA, MESSENGER; STRESS, PSYCHOLOGICAL; TRANSCRIPTION, GENETIC; TYROSINE 3-MONOOXYGENASE;

EID: 0034886177     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000937     Document Type: Article

References (79)

1. Hypericum extract-potential in the treatment of depression
2. Hypericum extract versus imipramine or placebo in patients with moderate depression: Randomised multicentre study of treatment for eight weeks
3. Effects of the total extract and fractions of Hypericum perforatum in animal assays for antidepressant activity
4. Pharmakologische. Untersuchungen zur antidepressiven wirkung von hypericum perforatum L.
5. Effects of hypericum extract (LI 160) in biochemical models of antidepressant activity
6. Extracts and constituents of Hypericum perforatum inhibit the binding of various ligands to recombinant receptors expressed with the Semliki Forest virus system
7. Biologically active and other chemical constituents of the herb of Hypericum perforatum L.
8. Hyperforin as a possible antidepressant component of hypericum extracts
9. +
10. Solubilized hypericin and pseudohypericin from Hypericum perforatum exert antidepressant activity in the forced swimming test
11. Flavonoids from Hypericum perforatum show antidepressant activity in the forced swimming test
12. Effects of Hypericum perforatum on levels of 5-hydroxy-tryptamine, noradrenaline and dopamine in the cortex, diencephalon and brainstem of the rat
13. In vitro receptor screening of pure constituents of St John's wort reveals novel interactions with a number of GPCR's
14. Pharmacological and endocrine effects of Hypericum perforatum and hypericin after repeated treatment
15. Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications
16. The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing hormone and tyrosine hydroxylase mRNA levels in rat brain: Therapeutic implications
17. Plasma concentrations of gamma-aminobutyric acid (GABA) and mood disorders: A blood test for manic depressive disease?
18. Open field behavior of rats reared in different social conditions: The effects of stress and imipramine
19. The gabaergic hypothesis of depression
20. Role of gamma-aminobutyric acid in antipanic drug efficacy
21. Antidepressants and hypothalamic-pituitary-adrenocortical regulation
22. Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system?
23. Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: Response to amitriptyline treatment
24. Repeated immobilization stress alters tyrosine hydroxylase, corticotropin-releasing hormone, and corticosteroid receptor mRNA levels in rat brain
25. Regulatory changes in neuroendocrine stress - Integrative circuitry produced by a variable stress paradigm
26. Local tetrodotoxin blocks chronic stress effects on corticotropin-releasing factor and vasopressin messenger ribonucleic acids in hypophysiotropic neurons
27. Effects of chronic social stress on tyrosine hydroxylase mRNA and protein levels
28. Region-specific regulation of glutamic acid decarboxylase (GAD) mRNA expression in central stress circuits
29. 1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: Implications for the neurobiology of depression
30. Effect of handing and forced immobilization on rat plasma levels of epinephrine, norepinephrine, and dopamine-β-hydroxylase
31. BDNF mRNA expression is increased in adult rat forebrain after limbic seizures: Temporal patterns of induction distinct from NGF
32. Acute and long-term treatments with the selective serotonin reputake inhibitor citalopram modulate the HPA axis activity at different levels in male rats
33. Role of serotonin in depression
34. 1A receptors in rat brain following antidepressant drug treatment
35. 3H]8-hydroxy-2-(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain
36. 1 sites in the rat brain
37. Serotonin receptors in suicide victims with major depression
38. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims
39. Chronic effects of imipramine and lithium on 5-HT receptor subtypes in rat frontal cortex, hippocampus and choroid plexus: Quantitative receptor autoradiographic analysis
40. 1A receptor mediated response by fluoxetine in rat brain
41. Chronic clomipramine alters presynaptic 5-HT(1B) and postsynaptic 5-HT(1A) receptor sensitivity in rat hypothalamus and hippocampus, respectively
42. Changes in the regulation of 5-hydroxytryptamine release by alpha2-adrenoceptors in the rat hippocampus after long-term desipramine treatment
43. Chronic antidepressant administration decreases the expression of tyrosine hydroxylase in the rat locus coeruleus
44. Neurocircuitry of stress: Central control of the hypothalamo-pituitary-adrenocortical axis
45. Responses of hypothalamic and pituitary mRNA to physical and psychological stress in the rat
46. The effects of restraint or hypertonic saline stress on corticotrophin-releasing factor, arginine vasopressin, and proenkephalin A mRNAs in the CFY, Sprague-Dawley and Wistar strains of rat
47. Restraint stress increases corticotropin-releasing hormone mRNA content in the amygdala and paraventricular nucleus
48. Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: Association with reduction in glucocorticoid receptor mRNA levels
49. Up-regulation of vasopressin mRNA in paraventricular hypophysiotrophic neurons after acute immobilization stress
50. In situ hybridization analysis of vasopressin gene transcription in the paraventricular and supraoptic nuclei of the rat: Regulation by stress and glucocorticoids
51. Corticotrophin-releasing factor, vasopressin and proopiomelanocortin mRNA responses to stress and opiates in the rat
52. Hypotensive hemorrhage elevates corticotropin-releasing hormone messenger ribonucleic acid (mRNA) but not vasopressin mRNA in the rat hypothalamus
53. Regulation of basal corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid expression in the paraventricular nucleus: Effects of selective hypothalamic deafferentations
54. Transient suppression of resting corticosterone levels induces sustained increase of AVP stores in hypothalamic CRH-neurons of rats
55. The arginine vasopressin and corticotrophin-releasing hormone gene transcription responses to varied frequencies of repeated stress in rats
56. Panic disorder. Pathophysiology and drug treatment
57. Chronic depression: Response to placebo, imipramine, and phenelzine
58. Desmethylimipramine enhances the release of endogenous GABA and other neurotransmitter amino acids from the rat thalamus
59. The organization of forebrain afferents to the paraventricular and supraoptic nuclei of the rat
60. Effects of phenelzine and imipramine on the steady-state levels of mRNAs that encode glutamic acid decarboxylase (GAD67 and GAD65), the GABA transporter GAT-1 and GABA transaminase in rat cortex
61. Glucocorticoids, transmitters and stress
62. Stress and antidepressant effects on hippocampal and cortical 5-HT1A and 5-HT2 receptors and transport sites for serotonin
63. Elevated basal trough levels of corticosterone suppress hippocampal 5-hydroxytryptamine(1A) receptor expression in adrenally intact rats: Implication for the pathogenesis of depression
64. PET imaging of serotonin 1A receptor binding in depression
65. 11C]WAY-100635: Effects of depression and antidepressant treatment
66. Adult brain neurogenesis and psychiatry: A novel theory of depression
67. Neurotrophic factors: From molecule to man
68. Evidence for hippocampal regulation of neuroendocrine neurons of the hypothalamo-pituitary-adrenocortical axis
69. Loss of glucocorticoid fast feedback in depression
70. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments
71. 2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism
72. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus
73. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus
74. Effect of chronic restraint stress and tianeptine on growth factors, growth-associated protein-43 and microtubule-associated protein 2 mRNA expression in the rat hippocampus
75. Stress, antidepressant drugs, and the locus coeruleus
76. Chronic imipramine treatment normalizes levels of tyrosine hydroxylase in the locus coeruleus of chronically stressed rats
77. Catecholamine effects upon rat hypothalamic corticotropin-releasing hormone secretion in vitro